New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainBy improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center succes
Oncology January 30,2024
Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

Enhanced recovery program shown to successfully reduce opioid use after pancreatic cancer surgery

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainBy improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center succes
Oncology January 30,2024
Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l
Oncology January 30,2024
Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l
Oncology January 30,2024
New genetic test for pancreatic cancer outperforms current guidelines

New genetic test for pancreatic cancer outperforms current guidelines

by University of PittsburghCredit: Pixabay/CC0 Public DomainA molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, mul
Oncology January 30,2024
New genetic test for pancreatic cancer outperforms current guidelines

New genetic test for pancreatic cancer outperforms current guidelines

by University of PittsburghCredit: Pixabay/CC0 Public DomainA molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, mul
Oncology January 30,2024
Radiation oncology workforce expected to remain stable through 2030

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10
Oncology January 30,2024
Radiation oncology workforce expected to remain stable through 2030

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10
Oncology January 30,2024
Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or
Oncology January 30,2024
Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or
Oncology January 30,2024
Increasingly under fire as potential health hazards, gas stoves could be banned in 2023

Increasingly under fire as potential health hazards, gas stoves could be banned in 2023

by Nara SchoenbergCredit: Pixabay/CC0 Public DomainCiting studies that link gas stoves to health problems, including asthma in children, a U.S. Consumer Product Safety Commission official said his age
Oncology January 30,2024
Increasingly under fire as potential health hazards, gas stoves could be banned in 2023

Increasingly under fire as potential health hazards, gas stoves could be banned in 2023

by Nara SchoenbergCredit: Pixabay/CC0 Public DomainCiting studies that link gas stoves to health problems, including asthma in children, a U.S. Consumer Product Safety Commission official said his age
Oncology January 30,2024
Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m
Oncology January 30,2024
Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m
Oncology January 30,2024
Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

by Brown UniversityGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101019A new study shows how a drug made from a natural compound used in traditional
Oncology January 30,2024
Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors

by Brown UniversityGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101019A new study shows how a drug made from a natural compound used in traditional
Oncology January 30,2024
Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct
Oncology January 30,2024
Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct
Oncology January 30,2024
Researchers identify protein linked to heart failure in chemo patients

Researchers identify protein linked to heart failure in chemo patients

by University of ManitobaCredit: CC0 Public DomainA team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called
Oncology January 30,2024
Researchers identify protein linked to heart failure in chemo patients

Researchers identify protein linked to heart failure in chemo patients

by University of ManitobaCredit: CC0 Public DomainA team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com